Current State-Of-Play of the EU Advanced Therapy Medicinal Product (ATMP) Field, With an Emphasis on Belgian Human Cell and Tissue Products.
AuteursVerbeken G, Convents L, Delmotte N, Draye JP, Jennes S, Vanderkelen A, Nijs G, Lewalle P, Baudoux E, Cornu O, Vanlaere I, Pierlot A, Rose T, Pirnay JP
Lessons Learnt From Running a Transition-Age Youth Mental Health Outpatient Clinic in Italy: The PRecocity of Intervention in Adolescent Medicine (PRIMA) Experience.
AuteursColizzi M, Basaldella M, Candolo A, Garzitto M, Palermo A, Scipioni C, Tavian G, Balestrieri M, Bortoletto R, Comacchio C
Off-label use of biologics in urticarial vasculitis: a European retrospective cohort study.
AuteursMaisonobe L, Korganow AS, Berti A, Deroux A, Dupin N, Aractingi S, Emmi G, Vandergheynst F, Fabre M, Kluger N, Roux M, Abisror N, Benyamine A, Cassone G, Chasset F, Doutre MS, Foucher A, Freguin C, Gobert D, Gombeir Y, Hernandez-Rodriguez J, Legouellec N, Pinault AL, Titeca D, Jachiet M, Terrier B
Quality-of-Life Measurement in Epidermolysis Bullosa. Position Statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient-Oriented Outcomes and External Experts.
AuteursChernyshov PV, Finlay AY, Tomas-Aragones L, Poot F, Murrell DF, Pustisek N, Svensson A, Marron SE, Sampogna F, Bewley A, Salavastru C, Koumaki D, Suru A, Yordanova IA, Zemskov S, Tsymbaliuk R, Ostapko O, Augustin M, Abeni D, Szepietowski JC, Jemec GB
